Abstract
The prevention of cancer-treatment-induced bone loss due to chemotherapy and long-term adjuvant breast cancer therapy has a high priority. We present an algorithm for the prevention and treatment of osteoporosis during treatment of nonmetastatic breast cancer.
MeSH terms
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / adverse effects*
-
Bone Density Conservation Agents / administration & dosage
-
Bone Density Conservation Agents / therapeutic use
-
Breast Neoplasms / drug therapy*
-
Diphosphonates / administration & dosage
-
Diphosphonates / therapeutic use
-
Female
-
Glucocorticoids / administration & dosage
-
Glucocorticoids / adverse effects
-
Humans
-
Osteoporosis* / chemically induced
-
Osteoporosis* / diagnosis
-
Osteoporosis* / drug therapy
-
Osteoporosis* / prevention & control
-
Osteoporotic Fractures / chemically induced
-
Osteoporotic Fractures / prevention & control
-
Practice Guidelines as Topic
-
Prednisolone / administration & dosage
-
Prednisolone / adverse effects
-
Risk Factors
Substances
-
Antineoplastic Agents
-
Bone Density Conservation Agents
-
Diphosphonates
-
Glucocorticoids
-
Prednisolone